The purpose of Core B is three-fold: 1. To maintain and expand a complete and interactive database with accurate and robust demographic, phenotypic and clinical information that Is readily linked to the basic science information. 2. To provide investigators of Projects 1-5 with defined tissue samples (including DNA, serum, serology, cell lines, endoscopic biopsies, surgical resection tissues) as they are required and to ensure appropriate and evenhanded distribution to all projects. 3. To continue to 'call-back' patients with defined genetic, immunological or functional characteristics for re-sampling as required and requested by the projects. Core B obtains, processes and distributes tissues and also provides data management and both statistical advice and analyses in support of the projects. Blood, surgical and mucosal samples are processed for experimental use and/or storage, and comprehensive clinical, demographic and phenotypic data is gathered and entered into the secure database. All tissue samples are linked with the demographic, phenotypic and natural history data as well as with the associated immunologic and genetic parameters in an anonymized fashion. Following informed consent the procurement technician collects samples from clinical and research study patients at physician visits, endoscopic procedures and coordinates with surgeons and pathologists to obtain mucosal samples from intestinal resections. Populations are stratified according to a variety of clinical, subclinical, genetic and epidemiologic parameters. The services provided by Core B continue to expand with further intensification of clinical data collection and the recent expansion of genetic data. Database expansion to incorporate these and other data necessitate database management and statistical services to facilitate experiment design and data interpretation. The Research Studies Coordinators will help to identify and contact study populations and help with sample collection. Additional clinical services will be provided in cooperation with the Cedars-Sinai General Clinical Research Center.

Public Health Relevance

Inflammatory bowel diseases affect more than one million Americans and the incidence is rising. The work described in the program project proposal will further understanding of the causes of these diseases and aid In the development of patient-specific therapies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK046763-21
Application #
8566151
Study Section
Special Emphasis Panel (ZDK1-GRB-8 (O1))
Project Start
1997-09-30
Project End
2015-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
21
Fiscal Year
2012
Total Cost
$314,531
Indirect Cost
$128,920
Name
Cedars-Sinai Medical Center
Department
Type
DUNS #
075307785
City
Los Angeles
State
CA
Country
United States
Zip Code
90048
Brant, Steven R; Okou, David T; Simpson, Claire L et al. (2017) Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Gastroenterology 152:206-217.e2
Volkmann, Elizabeth R; Hoffmann-Vold, Anna-Maria; Chang, Yu-Ling et al. (2017) Systemic sclerosis is associated with specific alterations in gastrointestinal microbiota in two independent cohorts. BMJ Open Gastroenterol 4:e000134
Gonsky, Rivkah; Fleshner, Phillip; Deem, Richard L et al. (2017) Association of Ribonuclease T2 Gene Polymorphisms With Decreased Expression and Clinical Characteristics of Severity in Crohn's Disease. Gastroenterology 153:219-232
Schwerd, T; Bryant, R V; Pandey, S et al. (2017) NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease. Mucosal Immunol :
Zhang, Hong; Zheng, Libo; McGovern, Dermot P B et al. (2017) Myeloid ATG16L1 Facilitates Host-Bacteria Interactions in Maintaining Intestinal Homeostasis. J Immunol 198:2133-2146
Xu, Chunlan; Ghali, Sally; Wang, Jiani et al. (2017) CSA13 inhibits colitis-associated intestinal fibrosis via a formyl peptide receptor like-1 mediated HMG-CoA reductase pathway. Sci Rep 7:16351
Zhang, Hong; Zheng, Libo; Chen, Jeremy et al. (2017) The protection role of Atg16l1 in CD11c+dendritic cells in murine colitis. Immunobiology 222:831-841
Rivas, Manuel A; Graham, Daniel; Sulem, Patrick et al. (2016) A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis. Nat Commun 7:12342
Hoang-Yen Tran, D; Hoang-Ngoc Tran, D; Mattai, S A et al. (2016) Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor. Int J Obes (Lond) 40:1424-34
van der Gracht, Esmé; Zahner, Sonja; Kronenberg, Mitchell (2016) When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD. Mediators Inflamm 2016:9765238

Showing the most recent 10 out of 254 publications